HALO · Halozyme Therapeutics, Inc.
$98.66
-2.01 (-2.00%)
At close · Aug 14
Market Cap
$11.20B
Shares
113.50M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-09 | 750 | $80.37 | $60,278 |
| 2026-07-06 | 4,643 | $79.45 | $368,886 |
| 2026-06-29 | 24,256 | $74.96 | $1,818,230 |
| 2026-06-26 | 8,279 | $72.64 | $601,387 |
| 2026-06-25 | 3,517 | $71.15 | $250,235 |
| 2026-06-24 | 3,233 | $69.62 | $225,081 |
| 2026-06-18 | 6 | $68.57 | $411 |
| 2026-06-15 | 129 | $69.50 | $8,966 |
| 2026-06-10 | 47 | $71.48 | $3,360 |
| 2026-06-05 | 29,083 | $71.60 | $2,082,343 |
| 2026-05-26 | 1,046 | $68.32 | $71,463 |
| 2026-05-20 | 6 | $68.73 | $412 |
| 2026-05-19 | 16 | $67.44 | $1,079 |
| 2026-05-18 | 437 | $67.12 | $29,331 |
Showing 1–14 of 14 settlements
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
595 filings
579 filers
Visit website
Investor relations